Bound to bleed: How altered albumin binding may dictate warfarin treatment outcome

Although non-vitamin-K anticoagulants are now the preferred option for stroke prevention in atrial fibrillation (AF), warfarin is still used in a significant number of patients. Warfarin dosing requirements are susceptible to drug interactions and genetic polymorphisms in metabolising enzymes. Human...

Descripción completa

Detalles Bibliográficos
Autores principales: Fender, Anke C., Dobrev, Dobromir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6437285/
https://www.ncbi.nlm.nih.gov/pubmed/30963099
http://dx.doi.org/10.1016/j.ijcha.2019.02.007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6437285/
https://www.ncbi.nlm.nih.gov/pubmed/30963099
http://dx.doi.org/10.1016/j.ijcha.2019.02.007

Ejemplares similares